Vivo Opportunity Fund, L.p. - Net Worth and Insider Trading
Vivo Opportunity Fund, L.p. Net Worth
The estimated net worth of Vivo Opportunity Fund, L.p. is at least $183 Million dollars as of 2024-05-23. Vivo Opportunity Fund, L.p. is the 10% Owner of Sierra Oncology Inc and owns about 3,329,512 shares of Sierra Oncology Inc (SRRA) stock worth over $183 Million. Details can be seen in Vivo Opportunity Fund, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Vivo Opportunity Fund, L.p. has not made any transactions after 2022-01-31 and currently still holds the listed stock(s).
Transaction Summary of Vivo Opportunity Fund, L.p.
Vivo Opportunity Fund, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Vivo Opportunity Fund, L.p. owns 6 companies in total, including ALX Oncology Holdings Inc (ALXO) , Crinetics Pharmaceuticals Inc (CRNX) , and Sierra Oncology Inc (SRRA) among others .
Click here to see the complete history of Vivo Opportunity Fund, L.p.’s form 4 insider trades.
Insider Ownership Summary of Vivo Opportunity Fund, L.p.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc | 2020-07-21 | 10 percent owner |
| CRNX | Crinetics Pharmaceuticals Inc | 2020-01-29 | 10 percent owner |
| SRRA | Sierra Oncology Inc | 2022-01-31 | 10 percent owner |
 | | 2019-01-07 | 10 percent owner |
| | 2021-02-09 | 10 percent owner |
| | 2021-02-09 | 10 percent owner |
Vivo Opportunity Fund, L.p. Latest Holdings Summary
Vivo Opportunity Fund, L.p. currently owns a total of 1 stock. Vivo Opportunity Fund, L.p. owns 3,329,512 shares of Sierra Oncology Inc (SRRA) as of January 31, 2022, with a value of $183 Million.
Latest Holdings of Vivo Opportunity Fund, L.p.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SRRA | Sierra Oncology Inc | 2022-01-31 | 3,329,512 | 54.99 | 183,089,865 |
Holding Weightings of Vivo Opportunity Fund, L.p.
Vivo Opportunity Fund, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Vivo Opportunity Fund, L.p. has made a total of 1 transactions in Sierra Oncology Inc (SRRA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sierra Oncology Inc is the acquisition of 800,000 shares on January 31, 2022, which cost Vivo Opportunity Fund, L.p. around $22 Million.
Insider Trading History of Vivo Opportunity Fund, L.p.
- 1
Vivo Opportunity Fund, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Vivo Opportunity Fund, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Vivo Opportunity Fund, L.p. is 101.96%. GuruFocus also compares Vivo Opportunity Fund, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Vivo Opportunity Fund, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Vivo Opportunity Fund, L.p.'s insider trading performs compared to the benchmark.
Performance of Vivo Opportunity Fund, L.p.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.45 | | | | | |
| Relative Return to S&P 500(%) | 19.82 | | | | | |
Vivo Opportunity Fund, L.p. Ownership Network
Vivo Opportunity Fund, L.p. Owned Company Details
What does ALX Oncology Holdings Inc do?
Who are the key executives at ALX Oncology Holdings Inc?
Vivo Opportunity Fund, L.p. is the 10 percent owner of ALX Oncology Holdings Inc. Other key executives at ALX Oncology Holdings Inc include Chief Medical Officer Sophia Randolph , director & President and CEO Jaume Pons , and director & 10 percent owner Jason Lettmann .
ALX Oncology Holdings Inc (ALXO) Insider Trades Summary
Over the past 18 months, Vivo Opportunity Fund, L.p. made no insider transaction in ALX Oncology Holdings Inc (ALXO). Other recent insider transactions involving ALX Oncology Holdings Inc (ALXO) include a net sale of 93,208 shares made by Jaume Pons , a net sale of 10,528 shares made by Shelly Pinto , and a net sale of 13,605 shares made by Sophia Randolph .
In summary, during the past 3 months, insiders sold 102,000 shares of ALX Oncology Holdings Inc (ALXO) in total and bought 4,400 shares, with a net sale of 97,600 shares. During the past 18 months, 118,228 shares of ALX Oncology Holdings Inc (ALXO) were sold and 4,400 shares were bought by its insiders, resulting in a net sale of 113,828 shares.
ALX Oncology Holdings Inc (ALXO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ALX Oncology Holdings Inc Insider Transactions
Vivo Opportunity Fund, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Vivo Opportunity Fund, L.p.. You might contact Vivo Opportunity Fund, L.p. via mailing address: 192 Lytton Avenue, Palo Alto Ca 94301.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
